Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
SUBUDHI, SUMIT K.
One or more keywords matched the following items that are connected to SUBUDHI, SUMIT K.
Item TypeName
Academic Article Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".
Academic Article Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.
Academic Article Improving the therapeutic benefits of ipilimumab.
Academic Article Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy
Academic Article Interdependent IL-7 and IFN-? signalling in T-cell controls tumour eradication by combined a-CTLA-4+a-PD-1 therapy.
Academic Article Immune Checkpoint Therapies in Prostate Cancer.
Academic Article Modulation of EZH2 expression in T cells improves efficacy of anti-CTLA-4 therapy.
Academic Article Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers.
Academic Article Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis.
Concept CTLA-4 Antigen
Academic Article Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers-Response.
Academic Article New approaches to immunotherapy for metastatic castration-resistant prostate cancer.
Academic Article Differences in Tumor Microenvironment Dictate T Helper Lineage Polarization and Response to Immune Checkpoint Therapy.
Academic Article Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer.
Academic Article Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-na?ve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment.
Search Criteria
  • Interleukin 17